A. Wesley Burks, MD, Robert A. Wood, MD, Stacie M. Jones, MD, Scott H

Slides:

Advertisements

Similar presentations

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

Advertisements

Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy Scott.

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Advances in Diagnosing Peanut Allergy

Corinne A. Keet, MD, MS, Pamela A

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy Satya D. Narisety,

Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo- controlled multicenter trial David M. Fleischer, MD, A. Wesley Burks,

Fatty acids, inflammation, and asthma

Alison M. Hofmann, MD, Amy M. Scurlock, MD, Stacie M

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy Michael Kulis, PhD, Katie.

Advances in food allergy in 2015

Stacie M. Jones, MD, Scott H. Sicherer, MD, A

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Ann-Marie M. Schoos, MD, PhD, Jacob D

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults Peter S. Creticos, MD, Jennifer Maloney,

Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial Jens U. Ponikau, MD, David.

Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy Julie Wang, MD, Stacie M. Jones,

Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy Pamela A. Frischmeyer-Guerrerio, MD,

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study John M. Brehm, MD, MPH, Brooke Schuemann, BS,

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy Robert A.

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Fatty acids, inflammation, and asthma

Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial Martin Metz, MD, Andrea Schütz, MD, Karsten Weller, MD, Marina.

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy Helen A. Brough, MSc,

Food allergy: A practice parameter update—2014

A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response Pooja Varshney, MD, Stacie.

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Allergy testing in predicting outcome of open food challenge to peanut

A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.

Advances in Diagnosing Peanut Allergy

Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles Mayte Suárez-Fariñas,

Peter M. Wolfgram, MD, David B. Allen, MD

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy Satya D. Narisety,

Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens Brian P. Vickery, MD, Jing Lin, PhD, Michael Kulis, PhD, Zhiyan Fu,

Phillip Lieberman, MD, David Golden, MD

Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy Yamini V. Virkud, MD, MA, MPH, A. Wesley Burks,

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,

What is an “eosinophilic phenotype” of asthma?

Corinne A. Keet, MD, MS, Pamela A

Autophagy: Nobel Prize 2016 and allergy and asthma research

Development and cross-sectional validation of the Childhood Asthma Control Test Andrew H. Liu, MD, Robert Zeiger, MD, Christine Sorkness, PharmD, Todd.

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

House dust mite sublingual immunotherapy: Results of a US trial

Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy Scott.

Brian P. Vickery, MD, Jelena P. Berglund, PhD, Caitlin M

Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy Julie Wang, MD, Stacie M. Jones,

Prevention of food allergy: Beyond peanut

Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison Stacy J. Chin, MD, Brian P. Vickery, MD, Michael D. Kulis,

National prevalence and risk factors for food allergy and relationship to asthma: Results from the National Health and Nutrition Examination Survey

Jessica H. Savage, MD, MHS, Elizabeth C. Matsui, MD, MHS, Robert A

Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy Brian P. Vickery, MD, Amy M. Scurlock, MD, Michael Kulis,

The natural history of egg allergy in an observational cohort

Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study

Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch Stacie M. Jones, MD, Wence K. Agbotounou,

Dietary baked egg accelerates resolution of egg allergy in children

Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy Stacie M. Jones, MD, A.

Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts Susan L. Hefle, PhD, Terence J.

Macrolide antibiotics and asthma treatment

Mediator release assay for assessment of biological potency of German cockroach allergen extracts Anna H. Nowak-Wegrzyn, MD, Ramon Bencharitiwong, BS,

Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.

The natural history of milk allergy in an observational cohort

Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitization Edwin H. Kim, MD, J. Andrew Bird, MD, Michael Kulis,

Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen Piyush Patel, MD, Tom Holdich, MBBS,

The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.

Safety and efficacy of repeated monthly carboplatin desensitization

Natural history of cow’s milk allergy

Presentation transcript:

Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial A. Wesley Burks, MD, Robert A. Wood, MD, Stacie M. Jones, MD, Scott H. Sicherer, MD, David M. Fleischer, MD, Amy M. Scurlock, MD, Brian P. Vickery, MD, Andrew H. Liu, MD, Alice K. Henning, MS, Robert Lindblad, MD, Peter Dawson, PhD, Marshall Plaut, MD, Hugh A. Sampson, MD Journal of Allergy and Clinical Immunology Volume 135, Issue 5, Pages 1240-1248.e3 (May 2015) DOI: 10.1016/j.jaci.2014.12.1917 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Subject disposition. Journal of Allergy and Clinical Immunology 2015 135, 1240-1248.e3DOI: (10.1016/j.jaci.2014.12.1917) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 OFC results. Subjects were discontinued from treatment per protocol if they did not meet specific criteria at the year 2 OFC (OFC threshold ≥5000 mg or 10× baseline), and therefore the median values at year 3 are not presented. Blue stars indicate the group median at each time point. There was no statistically significant difference in medians between treatment groups. BL, Baseline. Journal of Allergy and Clinical Immunology 2015 135, 1240-1248.e3DOI: (10.1016/j.jaci.2014.12.1917) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Change from baseline in percentage of CD63+ basophils by 2-year response: all subjects. CPE, Crude peanut extract. Journal of Allergy and Clinical Immunology 2015 135, 1240-1248.e3DOI: (10.1016/j.jaci.2014.12.1917) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Peanut IgG4 levels by 2-year response for all subjects. *Subject-specific plots are shown, and blue stars indicate the group median at each time point. Repeated-measures analysis across all time points yielded a P value of .11, indicating that there was no statistically significant difference between 2-year responders compared with nonresponders. BL, Baseline. Journal of Allergy and Clinical Immunology 2015 135, 1240-1248.e3DOI: (10.1016/j.jaci.2014.12.1917) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 Peanut end point titration area under the curve by 2-year response for all subjects. *Subject-specific plots are shown, and blue stars indicate the group median at each time point. Repeated-measures analysis across time points through year 2 yielded a P value of .003, indicating there was a statistically significant decrease over time in 2-year responders compared with nonresponders. BL, Baseline. Journal of Allergy and Clinical Immunology 2015 135, 1240-1248.e3DOI: (10.1016/j.jaci.2014.12.1917) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions